Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DH02	AROPEM	G	Meropenem - 0.5g	0.5g	Injectable powder for solution	19,022,727 L.L
J01DH02	ARCHIFAR	G	Meropenem - 1g	1g	Injectable powder for solution	6,443,725 L.L
J01DH02	AROPEM	G	Meropenem (trihydrate) - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	995,723 L.L
J01DH02	AROPEM	G	Meropenem - 1g	1g	Injectable powder for solution	19,022,727 L.L
J01FA10	ARATRO	G	Azithromycin - 200mg/5ml	200mg/5ml	Powder for suspension	765,990 L.L
J01FA10	ARATRO	G	Azithromycin - 200mg/5ml	200mg/5ml	Powder for suspension	403,153 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension + solvent	365,525 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	693,423 L.L
J01FA10	AZOMYNE	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	237,860 L.L
J01FA10	APO-AZITHROMYCIN Z	G	Azithromycin - 250mg	250mg	Tablet	481,096 L.L
J01FA10	AZICIN 250 BENTA	G	Azithromycin - 250mg	250mg	Tablet, film coated	423,630 L.L
J01FA10	AZIFAST 250	G	Azithromycin - 250mg	250mg	Tablet, film coated	423,630 L.L
J01FA10	AZOMYCIN	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	361,494 L.L
J01FA10	AZOMYNE	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	385,683 L.L
J01FA10	AZOX 250	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	346,711 L.L
J01FA10	AZOX 250	G	Azithromycin (dihydrate) - 250mg	250mg	Tablet, film coated	354,774 L.L
J01FA10	ARATRO	G	Azithromycin - 500mg	500mg	Tablet, film coated	485,127 L.L
J01FA10	AZICIN 500 BENTA	G	Azithromycin - 500mg	500mg	Tablet, film coated	573,373 L.L
J01FA10	AZIFAST 500	G	Azithromycin - 500mg	500mg	Tablet, film coated	573,373 L.L
J01FA10	AZM-500	G	Azithromycin - 500mg	500mg	Tablet, film coated	448,843 L.L
J01GB06	AMICINE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	1,749,683 L.L
J01GB06	AMIKACIN SULPHATE	G	Amikacin (sulfate) - 500mg/2ml	500mg/2ml	Injectable solution	372,244 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,087,169 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	1,521,230 L.L
J01MA14	AVITAR 400	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	913,813 L.L
J01MA14	AVITAR 400	G	Moxifloxacin (HCl) - 400mg	400mg	Tablet, film coated	651,764 L.L
J01MA14	AVALOX	B	Moxifloxacin (HCl) - 400mg/250ml	400mg/250ml	Injectable solution	9,052,935 L.L
J02AA01	AMBISOME	B	Liposomal Amphotericin B - 50mg	50mg	Injectable powder for liposomal dispersion	13,126,040 L.L

...